Author:
Mini E.,Nobili S.,Caciagli B.,Landini I.,Mazzei T.
Reference62 articles.
1. Synthesis of 2-deoxy-2′,2′difluoro-D-ribose and 2-deoxy-2′,2′difluoro-D-ribofuranosyl nucleosides;Hertel;J Org Chem,1988
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J Clin Oncol,1997
3. Phase III trial of gemcitabine plus cisplatin vs. cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer;Sandler;J Clin Oncol,2000
4. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
5. Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall survival;Albain;Proc. ASCO 22, No 14S (July 15 Supplement),2004
Cited by
610 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献